Citius Pharmaceuticals, Inc. (Nasdaq: CTXR) is a late-stage biopharmaceutical company focused on the development and commercialization of first-in-class critical care products, with a pipeline of anti-infectives in adjunct cancer care, oncology, stem cell therapy and unique prescription products. Our team’s extensive experience in the pharmaceutical industry allows us to identify compelling opportunities and develop assets

Citius Read More »


We help over 43 million people feel more confident in their most important financial goals, manage employee benefit programs for more than 23,000 businesses, and support more than 3,600 advisory firms* with innovative investment and technology solutions to grow their businesses. Our diverse businesses and independence give us insight into the entire market and the

Fidelity Read More »

Shopping Cart
Scroll to Top